2014
DOI: 10.4178/epih/e2014025
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Decision Analysis using Decision Tree

Abstract: The clinical decision analysis (CDA) has used to overcome complexity and uncertainty in medical problems. The CDA is a tool allowing decision-makers to apply evidence-based medicine to make objective clinical decisions when faced with complex situations. The usefulness and limitation including six steps in conducting CDA were reviewed. The application of CDA results should be done under shared decision with patients’ value.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
33
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 62 publications
(37 citation statements)
references
References 107 publications
(102 reference statements)
1
33
0
Order By: Relevance
“…Therefore, the decision trees should be viewed as descriptive explorative analysis explaining the data, but they are not confirming predictors. 35,36 In summary, the inclusion of the MCP in the automatized morphometric analysis corroborates previous neuropathological studies that showed that most MSA patients have a mixed SND and OPCA pathology and that brain atrophy patterns do not necessarily correspond to the clinical impression of predominant motor deficits. The combination of automated subcortical and supra-and infratentorial segmentation that included the volumetric measure of the MCP further improved the existing volumetric MRI decision support strategies on the diagnostic accuracy in separating MSA from PD.…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…Therefore, the decision trees should be viewed as descriptive explorative analysis explaining the data, but they are not confirming predictors. 35,36 In summary, the inclusion of the MCP in the automatized morphometric analysis corroborates previous neuropathological studies that showed that most MSA patients have a mixed SND and OPCA pathology and that brain atrophy patterns do not necessarily correspond to the clinical impression of predominant motor deficits. The combination of automated subcortical and supra-and infratentorial segmentation that included the volumetric measure of the MCP further improved the existing volumetric MRI decision support strategies on the diagnostic accuracy in separating MSA from PD.…”
Section: Discussionsupporting
confidence: 84%
“…Readers should also be aware that the decision trees, like any other statistical model, may change in structure if important variables are added or removed. Therefore, the decision trees should be viewed as descriptive explorative analysis explaining the data, but they are not confirming predictors …”
Section: Discussionmentioning
confidence: 99%
“…In fact, decision trees are reliable and effective decision making techniques used in different areas of medical decision making [45]. Meanwhile, in evidence-based medicine, it was used for clinical decision analysis [46].…”
Section: Methodsmentioning
confidence: 99%
“…All of the decision tree calculations (ie, “folding back”) and sensitivity analyses were carried out using dedicated computer software (TreePlan™ v.2.03 and SensIt™ v.1.53. TreePlan Software Inc., San Francisco, CA, USA), following generally accepted rules …”
Section: Methodsmentioning
confidence: 99%